QUZYTTIR (cetirizine hydrochloride injection), for intravenous use. Initial U.S. Approval: 1995

QUZYTTIR (cetirizine hydrochloride injection), for intravenous use. Initial U.S. Approval: 1995

QUZYTTIRTM is a histamine-1 (H1) receptor antagonist indicated for the treatment of acute urticaria in adults and children 6 months of age and older.
Limitations of Use:
Not recommended in pediatric patients less than 6 years of age with impaired renal or hepatic function.
Injection: 10 mg/mL cetirizine hydrochloride
Manufactured By: TerSera Therapeutics LLC
Prescribing Information URL: Click Here

Access to QUZYTTIR ™ (cetirizine hydrochloride injection): Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from Medvitaz Pharma Solutions.

Cetirizine, sold under the brand name Zyrtec among others, is a second-generation antihistamine used to treat allergic rhinitis (hay fever), dermatitis, and urticaria. It is taken by mouth. Effects generally begin within an hour and last for about a day. The degree of benefit is similar to other antihistamines such as diphenhydramine.It was patented in 1981 and came into medical use in 1987. It is available as a generic medication. In 2017, it was the 66th most commonly prescribed medication in the United States, with more than eleven million prescriptions.


There are no reviews yet.

Add a review

Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.